Jakesz R, Hausmaninger H, Samonigg H, Kubista E, Haider K, Mlineritsch B, Schmid M, Tausch C, Reiner G, Renner K, Stierer M, Jatzko G, Hofbauer F, Fridrik M, Schennach W, Sevelda P, Dadak C, Haid A, Scholz R, Lenzhofer P, Steindorfer P, Berger A, Mischinger H J
Klinische Abteilung für Allgemeinchirurgie, Universitätsklinik für Chirurgie Wien.
Zentralbl Chir. 1998;123 Suppl 5:28-32.
The Austrian Breast Cancer Group (ABC) consisting of more than 60 participating centers in Austria has randomized more than 5800 patients in 11 randomized trials since 1984. At present, roughly 30% of all patients with the diagnosis primary breast cancer are accrued in protocols throughout the country. Due to specific activities, the breast conservation rate raised from an initial 20% to more than 60% in the last years. Multicenter trials are not only the basis for progress in medicine but also tools for quality control and quality improvement.
奥地利乳腺癌研究小组（ABC）由奥地利60多个参与中心组成，自1984年以来，在11项随机试验中对5800多名患者进行了随机分组。目前，全国所有原发性乳腺癌诊断患者中约有30%纳入了相关方案。由于开展了特定活动，近年来保乳率从最初的20%提高到了60%以上。多中心试验不仅是医学进步的基础，也是质量控制和质量改进的工具。
